|
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION (Tables)
|
9 Months Ended |
|
Dec. 31, 2013
|
| STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION [Abstract] |
|
| Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs |
The following table summarizes share-based compensation (in thousands): | | | Three Months Ended | | Nine Months Ended | | | | December 31,
2013 | | December 31,
2012 | | December 31,
2013 | | December 31,
2012 | | Share-based compensation: | | | | | | | | | | | | | | Cost of revenue | | $ | 509 | | $ | 626 | | $ | 1,560 | | $ | 1,839 | | Research and development | | | 862 | | | 925 | | | 2,638 | | | 2,772 | | Sales and marketing | | | 994 | | | 1,273 | | | 3,148 | | | 3,603 | | General and administrative | | | 1,056 | | | 892 | | | 2,922 | | | 3,515 | | | | $ | 3,421 | | $ | 3,716 | | $ | 10,268 | | $ | 11,729 | | | | | | Share-based compensation by type of award: | | | | | | | | | | | | | | Stock options | | $ | 207 | | $ | 239 | | $ | 647 | | $ | 1,445 | | Restricted stock | | | 2,923 | | | 2,986 | | | 8,629 | | | 8,767 | | Stock purchase plan | | | 291 | | | 491 | | | 992 | | | 1,517 | | | | $ | 3,421 | | $ | 3,716 | | $ | 10,268 | | $ | 11,729 |
|
| Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions |
The weighted-average grant date fair values and the assumptions used in calculating fair values for the nine months ended December 31, 2013 and 2012 are as follows: | | | Nine Months Ended | | | | December 31,
2013 | | December 31,
2012 | | Option life (in years) | | | 0.5 | | | | 0.5 | | | Risk-free interest rate | | | 0.07 | % | | | 0.15 | % | | Stock price volatility | | | 47.65 | % | | | 74.81 | % | | Weighted-average grant date fair value | | $ | 0.47 | | | $ | 0.51 | |
|
| Schedule of Share-based Compensation, Stock Options, Activity |
A summary of activity relating to our stock options follows (options and aggregate intrinsic value in thousands): | | | Options | | Weighted-
Average
Exercise Price | | Weighted-
Average
Remaining
Contractual Term | | Aggregate
Intrinsic Value | | Outstanding as of March 31, 2013 | | 16,050 | | | $ | 2.14 | | | | | | | Exercised | | (535 | ) | | | 0.99 | | | | | | | Forfeited | | (1,108 | ) | | | 2.20 | | | | | | | Expired | | (3,011 | ) | | | 2.07 | | | | | | | Outstanding as of December 31, 2013 | | 11,396 | | | $ | 2.21 | | 1.66 | | $ | 1,031 | | Vested and expected to vest at December 31, 2013 | | 11,369 | | | $ | 2.20 | | 1.66 | | $ | 1,031 | | Exercisable as of December 31, 2013 | | 10,944 | | | $ | 2.19 | | 1.56 | | $ | 1,027 |
|
| Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity |
A summary of activity relating to our restricted stock follows (shares in thousands): | | | Shares | | Weighted-Average
Grant Date
Fair Value | | Nonvested at March 31, 2013 | | 9,887 | | | $ | 2.43 | | Granted | | 7,751 | | | | 1.40 | | Vested | | (4,241 | ) | | | 2.40 | | Forfeited | | (1,041 | ) | | | 2.06 | | Nonvested at December 31, 2013 | | 12,356 | | | $ | 1.83 |
|